Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Nov 23;18(12):2505.
doi: 10.3390/ijms18122505.

Long Non-Coding RNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Regulation, Functions, and Underlying Mechanisms

Affiliations
Review

Long Non-Coding RNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Regulation, Functions, and Underlying Mechanisms

Lipeng Qiu et al. Int J Mol Sci. .

Abstract

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third leading cause of cancer death in the world. Hepatitis B virus (HBV) and its X gene-encoded protein (HBx) play important roles in the progression of HCC. Although long non-coding RNAs (lncRNAs) cannot encode proteins, growing evidence indicates that they play essential roles in HCC progression, and contribute to cell proliferation, invasion and metastasis, autophagy, and apoptosis by targeting a large number of pivotal protein-coding genes, miRNAs, and signaling pathways. In this review, we briefly outline recent findings of differentially expressed lncRNAs in HBV-related HCC, with particular focus on several key lncRNAs, and discuss their regulation by HBV/HBx, their functions, and their underlying molecular mechanisms in the progression of HCC.

Keywords: HBV; HBx; HCC; apoptosis; autophagy; epithelial-mesenchymal transition; invasion and metastasis; lncRNAs; proliferation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Dysregulated long non-coding RNAs (lncRNAs) in hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) and their functions in HCC progression, including the modulation of HCC cell proliferation, invasion and metastasis, autophagy, and apoptosis [3,11,12,13,14,15,16,17,18,19,20,21,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43].
Figure 2
Figure 2
Several key lncRNAs aberrantly expressed in HBV-related HCC, their targets, and their underlying molecular mechanisms in HCC progression. (A) MALAT1 (metastasis-associated lung adenocarcinoma transcript 1); (B) HULC (highly upregulated in liver cancer); (C) UCA1 (urothelial carcinoma associated-1); (D) HOTAIR (HOX transcript antisense intergenic RNA); (E) H19 (imprinted maternally expressed untranslated mRNA); (F) MVIH (microvascular invasion in HCC).

References

    1. Venook A.P., Papandreou C., Furuse J., de Guevara L.L. The incidence and epidemiology of hepatocellular carcinoma: A global and regional perspective. Oncologist. 2010;15:5–13. doi: 10.1634/theoncologist.2010-S4-05. - DOI - PubMed
    1. Ridruejo E. Does hepatitis B virus therapy reduce the risk of hepatocellular carcinoma? Expert Opin. Drug Saf. 2015;14:439–451. doi: 10.1517/14740338.2015.998649. - DOI - PubMed
    1. Liang H.W., Wang N., Wang Y., Wang F., Fu Z., Yan X., Zhu H., Diao W., Ding Y., Chen X., et al. Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122. J. Hepatol. 2016;64:278–291. doi: 10.1016/j.jhep.2015.09.013. - DOI - PubMed
    1. Di Bisceglie A.M. Hepatitis B and hepatocellular carcinoma. Hepatology. 2009;49:S56–S60. doi: 10.1002/hep.22962. - DOI - PMC - PubMed
    1. Martin-Vilchez S., Lara-Pezzi E., Trapero-Marugan M., Moreno-Otero R., Sanz-Cameno P. The molecular and pathophysiological implications of hepatitis B X antigen in chronic hepatitis B virus infection. Rev. Med. Virol. 2011;21:315–329. doi: 10.1002/rmv.699. - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources